Medprin Regenerative Medical Technologies Co.,Ltd.’s Net Profit Rose 0.8% in First Half of 2022

Medprin Regenerative Medical Technologies Co.,Ltd. (广州迈普再生医学科技股份有限公司) (301033.SZ) reported a net profit of 21.1 million yuan in the first half of 2022, up 0.8% year-on-year.

Meanwhile, the company posted 95 million yuan in revenue, up 38.2% year-on-year.

At the end of the reporting period, it had 752.3 million yuan in total assets and 162.2 million yuan in total liabilities, with a liability-to-asset ratio of 21.6%.